These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39230002)

  • 1. Past, present, and future policy considerations regarding meningococcal vaccination in the United States.
    Clements DE; Olaiya T; Burman C; Herrera-Restrepo O; Sohn WY; Folaranmi T; Abbing-Karahagopian V; Marshall GS; Conway JH
    Expert Rev Vaccines; 2024; 23(1):845-861. PubMed ID: 39230002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential public health impact of a
    Huang L; Snedecor SJ; Balmer P; Srivastava A
    Postgrad Med; 2022 May; 134(4):341-348. PubMed ID: 33615973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.
    Mbaeyi SA; Bozio CH; Duffy J; Rubin LG; Hariri S; Stephens DS; MacNeil JR
    MMWR Recomm Rep; 2020 Sep; 69(9):1-41. PubMed ID: 33417592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal Vaccination of Adolescents in the United States: Past Successes and Future Considerations.
    Presa J; Findlow J; Zimet GD
    J Adolesc Health; 2024 Jun; 74(6):1068-1077. PubMed ID: 38430074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial.
    Peterson J; Drazan D; Czajka H; Maguire J; Pregaldien JL; Seppa I; Maansson R; O'Neill R; Balmer P; Jodar L; Jansen KU; Anderson AS; Perez JL; Beeslaar J
    Lancet Infect Dis; 2023 Dec; 23(12):1370-1382. PubMed ID: 37579773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of regional disparities on the availability of meningococcal vaccines in the US.
    Schley K; Jodar E; Presa JV; Willis SJ; Prener CG
    BMC Public Health; 2024 Jul; 24(1):1771. PubMed ID: 38961431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp.
    Burman C; Alderfer J; Snow VT
    J Clin Pharm Ther; 2020 Apr; 45(2):270-281. PubMed ID: 31820483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cohn AC; MacNeil JR; Clark TA; Ortega-Sanchez IR; Briere EZ; Meissner HC; Baker CJ; Messonnier NE;
    MMWR Recomm Rep; 2013 Mar; 62(RR-2):1-28. PubMed ID: 23515099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review.
    Begum S; Herrera-Restrepo O; Rolland C; Purushotham S; Andani A; Shah H; Kocaata Z
    Hum Vaccin Immunother; 2024 Dec; 20(1):2406613. PubMed ID: 39373020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.
    Mbaeyi S; Pondo T; Blain A; Yankey D; Potts C; Cohn A; Hariri S; Shang N; MacNeil JR
    JAMA Pediatr; 2020 Sep; 174(9):843-851. PubMed ID: 32687590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    Collins JP; Crowe SJ; Ortega-Sanchez IR; Bahta L; Campos-Outcalt D; Loehr J; Morgan RL; Poehling KA; McNamara LA
    MMWR Morb Mortal Wkly Rep; 2024 Apr; 73(15):345-350. PubMed ID: 38635488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines: A Phase 2 Randomized Study.
    Szenborn L; Block SL; Jackowska T; Konior R; D'Agostino D; Smolenov I; Toneatto D; Welsch JA
    Pediatr Infect Dis J; 2018 May; 37(5):475-482. PubMed ID: 29329168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial.
    Block SL; Szenborn L; Daly W; Jackowska T; D'Agostino D; Han L; Dull PM; Smolenov I
    Vaccine; 2015 May; 33(21):2500-10. PubMed ID: 25795256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring meningococcal serogroup B vaccination conversations under shared clinical decision-making in the US.
    Herrera-Restrepo O; Clements DE; Hebert ZN; McCracken C
    Curr Med Res Opin; 2024 Jul; 40(7):1253-1263. PubMed ID: 38860982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in healthcare providers' interpretations and implementations of ACIP's meningococcal vaccine recommendations.
    Huang L; Goren A; Lee LK; Li VW; Dempsey A; Srivastava A
    Hum Vaccin Immunother; 2020 Apr; 16(4):933-944. PubMed ID: 31634035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation Experience With Meningococcal Serogroup B Vaccines in the United States: Impact of a Nonroutine Recommendation.
    Fergie J; Howard A; Huang L; Srivastava A
    Pediatr Infect Dis J; 2021 Mar; 40(3):269-275. PubMed ID: 33565815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United States Physicians' Knowledge, Attitudes, and Practices Regarding Meningococcal Vaccination for Healthy Adolescents and Young Adults.
    Herrera-Restrepo O; Bunniran S; Mond T; Davenport E; Wang J; Sweeney C; Marshall GS
    J Adolesc Health; 2024 Jun; 74(6):1131-1138. PubMed ID: 38363244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.
    Srivastava A; Dempsey A; Galitsky A; Fahimi M; Huang L
    BMC Public Health; 2020 Jul; 20(1):1109. PubMed ID: 32664872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.